Sarc
Analysis
Sarc is a registered charity in United States, based in Ann Arbor, MI. It received its IRS tax-exemption ruling in August 2004, 22 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending December 2023, Sarc reported income of $3.7m and spending of $3.5m, spending 94% of its income. Across the 5 years on record, from December 2019 to December 2023, income fell from $4.4m to $3.7m (-16%), an average of -4.4% a year. The sharpest change came in the year to December 2020, when income dropped by 41%. Over the whole period it spent 104% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Sarc sits at the 77th percentile: it is larger than about 77% of them. Against every charity in United States with reported income it ranks in the 90th percentile, and in the 90th percentile within MI. Charities of a similar size with the same main cause include Arrow Consultation Services Inc ($3.7m), Spring Point Project ($3.7m) and LA Perla de Gran Precio Inc ($3.7m).
On its Form 990 for the period ending December 2023, revenue came from contributions and grants 97% and program service revenue 0.2% of the total. Compensation of current officers, directors and key employees was $310k (8.9% of expenses). Other salaries and wages came to $583k. At year end it held assets of $4.6m against liabilities of $378k, net assets of $4.3m. It reported 9 employees.
Income and spending
Where the income comes from
- Contributions & grants 97%
- Program services 0.2%
- Other 2.5%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Arrow Consultation Services Inc | Carmel | $3.7m |
| Spring Point Project | Minneapolis | $3.7m |
| LA Perla de Gran Precio Inc | San Juan | $3.7m |
| Center for Human Genetics Inc | Cambridge | $3.7m |